Industry subject matter experts spoke about the challenges of turning complex molecules into medicines patients can reliably ...

The pharmaceutical supply chain is a complex system with high stakes. USP provides insights on how it is helping industry ...

Jaenisch, Muraru, and Pandey discuss how regulators will audit pharma against its own AI policies and ways QA and regulatory ...

Impurity deficiencies in submissions are remarkably consistent. Subathra Ramamoorthy, Veranova, explains how to catch them ...